Send page
    21 Sep 2016

    Wistrand assists Diasend AB by the merger with Glooko, Inc.

    Diasend AB has partnered up with Glooko, Inc. and together they will be able to provide basic diabetes care worldwide. Wistrand has advised the owners of Diasend AB in the case.
    The new company, which will operate under the name Glooko, can in the merger offer their services to 4000 diabetes centers in 23 countries. In the future this joint solution can offer a greater support for people with diabetes - both during and between visits to the doctor. And as well provide additional functionality to caregivers considering the uploading and analysis of diabetes data.
    Wistrand's team was led by Per Dalemo (partner, M&A) and  Hendrik Kangasmuukko (lawyer, M&A) assisted by Jesper Sundström (lawyer, IP), Amanda Samuelsson (associate, M&A) and Henrik Nordling (associate, M&A).
    For more information:
    Per Dalemo, partner
    Tel: +46 31 771 21:38
    Mobile: +46 70 877 56 73


    25 Oct 2017
    Erik Ullberg and Gunilla Karlsson in GAL...
    09 Oct 2017
    Wistrand shortlisted for Sweden M&A Lega...
    20 Sep 2017
    Wistrand advises SBB on the acquisition ...
    15 Jun 2017
    Erik Ullberg in the book Sweepstakes & C...
    01 Jun 2017
    Wistrand advises SBB on the acquisition ...
    29 May 2017
    Labour Court rules on compensation for d...
    22 May 2017
    Erik Ullberg in GALA Gazette
    15 May 2017
    Wistrand advises in connection with the ...
    08 May 2017
    Wistrand advises Strawberry Properties o...
    28 Apr 2017
    Legal 500’s rankings for 2017 – Wistrand...
    11 Apr 2017
    Chambers Europe 2017 – Wistrand still hi...
    11 Apr 2017
    Wistrand advises Nokas on its acquisitio...